Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BC8-B10 |
Synonyms | |
Therapy Description |
BC8-B10 is a radioimmunoconjugate that contains anti-CD45 monoclonal antibody BC8 with its lysine side groups conjugated with decoborate and labeled with Astatine (PMID: 30335787). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BC8-B10 | astatine At 211 MAb BC8-B10|At 211 anti-CD45 BC8-B10|At 211 MAb BC8-B10 | BC8-B10 is a radioimmunoconjugate that contains anti-CD45 monoclonal antibody BC8 with its lysine side groups conjugated with decoborate and labeled with Astatine (PMID: 30335787). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|